Report Information More information from: https://www.wiseguyreports.com/reports/1283827
Biosimulation Market - Forecasts from 2017 to 2022 Report / Search Code: WGR1283827
Price
1-user PDF : $ 4200.0
Description:
Publish Date: 26 December, 2016
1-5 User PDF : $ 5200.0
Enterprise PDF : $ 7200.0
Biosimulation is used in the healthcare sector for model-based calculation of biological systems. It is helpful in making commercial decisions regarding the benefits of bringing a specific drug to market. In 2022, the market for biosimulation is expected to reach US$3,435 million, increasing from US$1,476 million in 2017. During this period it is projected to grow at a CAGR of 18.40%. Factors driving the biosimulation market growth are increased medical research and development across emerging economies, technological advancement in drug development processes, robust pace of clinical trials and a favourable regulatory environment in developed regions like the US and Europe. Rising demand for reduced drug development costs coupled with penetration of digital and computer technology and improvement in modeling tools has fuelled further market growth. Geographically, North America is the expected to remain the largest biosimulation market over the projected period followed by Europe. Research Methodology This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report. Market Dynamics In this section, the entire market is explained along with various drivers, restraints, and opportunities which exist in the current market. This section of the report also provides product pipeline, industry value chain analysis, and innovations in the market. Various regulations in the industry along with a scenario analysis have also been covered as a part of this report section. Segmentation Biosimulation market has been segmented on the basis of type, application, end user and geography as follows: By Type Software Services By Application Drug Development Drug Discovery Others By End-User Pharmaceutical Companies Academic Institutes Research Organizations Others By Geography Americas North America South America Europe Middle East and Africa Europe The Middle East and Africa Asia Pacific Market Players The competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Rhenovia Pharma Ltd., Certara USA, Inc., Simulation Plus Inc., and Dassault SA among others.
Contents:
1. Introduction 2. Research Methodology 3. Executive Summary 4. Market Dynamics 4.1. Market Overview and Segmentations 4.2. Drivers 4.3. Restraints 4.4. Opportunities 4.5. Industry Value Chain Analysis 4.6. Product Pipeline 4.7. Innovations 4.8. Industry Regulations 4.9. Scenario Analysis 5. Biosimulation Market Forecast by Type (US$ million) 5.1. Software 5.2. Services 6. Biosimulation Market Forecast by Application (US$ million) 6.1. Drug Development 6.2. Drug Discovery 6.3. Others 7. Biosimulation Market Forecast by End-User (US$ million) 7.1. Pharmaceutical Companies 7.2. Academic Institutes 7.3. Research Organizations 7.4. Others 8. Biosimulation Market by Geography (US$ million) 8.1. Americas 8.1.1. North America 8.1.2. South America 8.2. Europe Middle East and Africa 8.2.1. Europe 8.2.2. The Middle East and Africa 8.3. Asia Pacific 9. Competitive Intelligence 9.1. Market Share of Key Players 9.2. Investment Analysis 9.3. Recent Deals 9.4. Strategies of Key Players 10. Company Profiles 10.1. Rhenovia Pharma Ltd. 10.2. Certara USA, Inc. 10.3. Simulation Plus Inc. 10.4. Dassault SA 10.5. Schrodinger Inc. 10.6. Advanced Chemistry Development, Inc. 10.7. Physiomics PLC 10.8. Chemical Computing Group List of Tables Table 1: Biosimulation Market Forecast, 2017 to 2022, US$ million Table 2: Biosimulation Market Forecast, 2017 to 2022, By Type, US$ million Table 3: Biosimulation Market Forecast, 2017 to 2022, By Type, Software, By Region, US$ million Table 4: Biosimulation Market Forecast, 2017 to 2022, By Type, Services, By Region, US$ million Table 5: Biosimulation Market Forecast, 2017 to 2022, By Application, US$ million Table 6: Biosimulation Market Forecast, 2017 to 2022, By Application, Drug Development, By Region, US$ million Table 7: Biosimulation Market Forecast, 2017 to 2022, By Application, Drug Discovery, By Region, US$ million Table 8: Biosimulation Market Forecast, 2017 to 2022, By Application, Others, By Region, US$ million Table 9: Biosimulation Market Forecast, 2017 to 2022, By End-User, US$ million Table 10: Biosimulation Market Forecast, 2017 to 2022, By End-User, Pharmaceutical Companies, By Region, US$ million Table 11: Biosimulation Market Forecast, 2017 to 2022, By End-User, Academic Institutes, By Region, US$ million Table 12: Biosimulation Market Forecast, 2017 to 2022, By End-User, Research Organizations, By Region, US$ million
Table 13: Biosimulation Market Forecast, 2017 to 2022, By End-User, Others, By Region, US$ million Table 14: Biosimulation Market Forecast, 2017 to 2022, By Region, US$ million Table 15: Biosimulation Market Forecast, 2017 to 2022, By Region, Americas, US$ million Table 16: Biosimulation Market Forecast, 2017 to 2022, By Region, Europe Middle East and Africa, US$ million Table 17: Biosimulation Market Forecast, 2017 to 2022, By Region, Asia Pacific, US$ million Table 18: Biosimulation Market Forecast, 2017 to 2022, By Type, North America, US$ million Table 19: Biosimulation Market Forecast, 2017 to 2022, By Application, North America, US$ million Table 20: Biosimulation Market Forecast, 2017 to 2022, By End User, North America, US$ million Table 21: Biosimulation Market Forecast, 2017 to 2022, By Type, South America, US$ million Table 22: Biosimulation Market Forecast, 2017 to 2022, By Application, South America, US$ million Table 23: Biosimulation Market Forecast, 2017 to 2022, By End User, South America, US$ million Table 24: Biosimulation Market Forecast, 2017 to 2022, By Type, Europe, US$ million Table 25: Biosimulation Market Forecast, 2017 to 2022, By Application, Europe, US$ million Table 26: Biosimulation Market Forecast, 2017 to 2022, By End User, Europe, US$ million Table 27: Biosimulation Market Forecast, 2017 to 2022, By Type, Middle East and Africa, US$ million Table 28: Biosimulation Market Forecast, 2017 to 2022, By Application, Middle East and Africa, US$ million Table 29: Biosimulation Market Forecast, 2017 to 2022, By End User, Middle East and Africa, US$ million Table 30: Biosimulation Market Forecast, 2017 to 2022, By Type, Asia Pacific, US$ million Table 31: Biosimulation Market Forecast, 2017 to 2022, By Application, Asia Pacific, US$ million Table 32: Biosimulation Market Forecast, 2017 to 2022, By End User, Asia Pacific, US$ million
wiseguyreports.com / Phone (US) + 1-646-845-9349 (UK) +44 208 133 9349